Literature DB >> 17186028

Amplification of apoptosis through sequential caspase cleavage of the MET tyrosine kinase receptor.

B Foveau1, C Leroy, F Ancot, J Deheuninck, Z Ji, V Fafeur, D Tulasne.   

Abstract

Activation of the MET tyrosine kinase receptor by hepatocyte growth factor/scatter factor is classically associated with cell survival. Nonetheless, stress stimuli can lead to a caspase-dependent cleavage of MET within its juxtamembrane region, which generate a proapoptotic 40 kDa fragment (p40 MET). We report here that p40 MET is in fact generated through an additional caspase cleavage of MET within its extreme C-terminal region, which removes only few amino acids. We evidenced a hierarchical organization of these cleavages, with the C-terminal cleavage favoring the juxtamembrane one. As a functional consequence, the removal of the last amino acids of p40 MET increases its apoptotic capacity. Finally, cells expressing a MET receptor mutated at the C-terminal caspase site are unable to generate p40 MET and are resistant to apoptosis, indicating that generation of p40 MET amplifies apoptosis. These results revealed a two-step caspase cleavage of MET resulting in the reshaping of this survival receptor to a proapoptotic factor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17186028     DOI: 10.1038/sj.cdd.4402080

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  25 in total

1.  Down-regulation of the met receptor tyrosine kinase by presenilin-dependent regulated intramembrane proteolysis.

Authors:  Bénédicte Foveau; Frédéric Ancot; Catherine Leroy; Annalisa Petrelli; Karina Reiss; Valérie Vingtdeux; Silvia Giordano; Véronique Fafeur; David Tulasne
Journal:  Mol Biol Cell       Date:  2009-03-18       Impact factor: 4.138

2.  Dependence receptors: mechanisms of an announced death.

Authors:  Chantal Thibert; Joanna Fombonne
Journal:  Cell Cycle       Date:  2010-06-01       Impact factor: 4.534

Review 3.  Receptor tyrosine kinases in the nucleus.

Authors:  Graham Carpenter; Hong-Jun Liao
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-10-01       Impact factor: 10.005

4.  Novel Death Defying Domain in Met entraps the active site of caspase-3 and blocks apoptosis in hepatocytes.

Authors:  Jihong Ma; Chunbin Zou; Lida Guo; Danushka S Seneviratne; Xinping Tan; Yong-Kook Kwon; Jiyan An; Robert Bowser; Marie C DeFrances; Reza Zarnegar
Journal:  Hepatology       Date:  2014-04-01       Impact factor: 17.425

Review 5.  The N-end rule pathway and regulation by proteolysis.

Authors:  Alexander Varshavsky
Journal:  Protein Sci       Date:  2011-08       Impact factor: 6.725

6.  Caspases shutdown nonsense-mediated mRNA decay during apoptosis.

Authors:  J Jia; A Furlan; S Gonzalez-Hilarion; C Leroy; D C Gruenert; D Tulasne; F Lejeune
Journal:  Cell Death Differ       Date:  2015-03-06       Impact factor: 15.828

Review 7.  Trafficking of receptor tyrosine kinases to the nucleus.

Authors:  Graham Carpenter; Hong-Jun Liao
Journal:  Exp Cell Res       Date:  2008-10-11       Impact factor: 3.905

8.  Dependence receptor UNC5D mediates nerve growth factor depletion-induced neuroblastoma regression.

Authors:  Yuyan Zhu; Yuanyuan Li; Seiki Haraguchi; Meng Yu; Miki Ohira; Toshinori Ozaki; Atsuko Nakagawa; Toshikazu Ushijima; Eriko Isogai; Haruhiko Koseki; Yohko Nakamura; Cuize Kong; Patrick Mehlen; Hirofumi Arakawa; Akira Nakagawara
Journal:  J Clin Invest       Date:  2013-06-17       Impact factor: 14.808

9.  Anti-apoptotic role of caspase-cleaved GAB1 adaptor protein in hepatocyte growth factor/scatter factor-MET receptor protein signaling.

Authors:  Arnaud Le Goff; Zongling Ji; Bérénice Leclercq; Roland P Bourette; Alexandra Mougel; Cateline Guerardel; Yvan de Launoit; Jérôme Vicogne; Gautier Goormachtigh; Véronique Fafeur
Journal:  J Biol Chem       Date:  2012-08-22       Impact factor: 5.157

10.  A multi-factor model for caspase degradome prediction.

Authors:  Lawrence J K Wee; Joo Chuan Tong; Tin Wee Tan; Shoba Ranganathan
Journal:  BMC Genomics       Date:  2009-12-03       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.